NSC |
Compound |
Enrichment |
Correlation |
NSC 150311 |
2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- |
0.000316293616993019 |
-0.32569352 |
NSC 620687 |
Null |
0.000316293616993019 |
-0.31695929 |
NSC 648265 |
[3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin |
0.000316293616993019 |
-0.34520483 |
NSC 720147 |
Null |
0.000316293616993019 |
-0.25864219 |
NSC 630684 |
8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone |
0.000323852502732644 |
0.70875343 |
NSC 221266 |
Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy |
0.000332787192635313 |
-0.20416362 |
NSC 756134 |
GSK1023156A |
0.000332787192635313 |
-0.33602229 |
NSC 762566 |
Null |
0.000380874609232495 |
0.5884063 |
NSC 658143 |
2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin |
0.000380874609232497 |
-0.48296707 |
NSC 674276 |
Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- |
0.000380874609232497 |
0.49644676 |